Patients with MEN1 syndrome have inactivating pathogenic variants of the MEN1 gene that increase susceptibility to parathyroid tumors, pituitary tumors, pancreatic neuroendocrine tumors, and unilateral or bilateral adrenal tumors, including adrenocortical carcinoma. The gene discussed is MEN1; the disease is adrenal cortex carcinoma.